Determination of 5-ASA in whole or partial mesalamine delayed-release tablets recovered from fecal samples of healthy volunteers

被引：14

|

作者：

Safdi, AV ^{[1
]}

机构：

[1] Deaconess Hosp, Cincinnati, OH USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期

关键词：

D O I：

10.14309/00000434-200509001-00412

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

412

引用

收藏

页码：S159 / S159

页数：1

相关论文

共 24 条

[21] Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers
Brunner, M
Greinwald, R
Kletter, K
Kvaternik, H
Corrado, ME
Eichler, HG
Müller, M
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (09) : 1163 - 1169
[22] MD-7246, a Delayed-Release Formulation of Linaclotide Targeting Visceral Pain Associated With IBS-D, Does Not Impact Bowel Frequency or Stool Consistency in Healthy Volunteers: Results From Phase I Trial
Kuo, Braden
Bartolini, Wilmin
Tripp, Kenneth
Boinpally, Ramesh
Borgstein, Niels
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S289 - S289
[23] Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Angiolillo, Dominick J.
Datto, Catherine
Raines, Shane
Yeomans, Neville D.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (01) : 11 - 23
[24] Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Dominick J. Angiolillo
Catherine Datto
Shane Raines
Neville D. Yeomans
Journal of Thrombosis and Thrombolysis, 2014, 38 : 11 - 23